Each one in plain English, with the numbers worked through for a shareholder.
12 Mar 2024director officer appointment● Neutral
Non-executive director Andrea Hall resigned effective immediately. She was a director since April 2023 and chaired the Risk & Sustainability Committee. She said she was retiring to enable a board fit for the future; a successor chair for that committee is to be announced.
S&P Dow Jones index notice listing Core Lithium among the removals from the S&P/ASX 200 index, effective 18 March 2024. It is a third-party index change, not a company announcement; it generates no business information.
28 Feb 2024material agreement termination▼ BadMajor
The Lucas mining services contract (signed Sept 2021) is terminated by mutual agreement, with Core paying Lucas A$10M. Stockpile processing continues to mid-2024. Core will look for alternative mining solutions if open pit mining restarts, which has been suspended since January.
Core says its 2023 exploration program (over 68,000m drilled) is complete. BP33 hole NMRD085 hit 90.17m @ 1.80% Li2O, not yet in the resource model. Lees-Booths and Penfolds results are being interpreted for resource updates; the newest-target drill results are pending.
Slide presentation accompanying the December quarterly report. Only the disclaimer pages are visible in the text provided, so no new information can be confirmed.
Administrative notice that the December quarterly report will be released on 24 January 2024, with an investor call that day and a retail shareholder webcast on 25 January. No new business information.
Strategic review outcome: Grants open pit mining is temporarily suspended and processing continues from about 280,000t of stockpiles, enough until mid-2024. BP33 early works stay paused after box cut completion. Core flags a likely impairment of Finniss in half-year results.
A strategic review is under way because spodumene concentrate prices have fallen over 80% this year, over 40% since end-October. BP33 early works are suspended, and mining may be temporarily curtailed. Processing of the ROM stockpile continues through the wet season.
Chair's AGM address reviews FY23 and the A$108M equity raising, with A$202M cash and no debt at 30 September. It says spodumene prices have been weak, and the company is taking a prudent approach to staging expansion. No new numbers.
Site visit presentation on the Grants operation and BP33 project. Only the disclaimer pages are visible, so no new information can be confirmed from the text provided.
Administrative notice of a retail shareholder webinar on 14 November 2023, hosted by the CEO and CFO, covering Grants operations, BP33 progress and FY24 growth strategy. No new business information.
Slide presentation accompanying the September quarterly report, an investor call hosted by CEO Gareth Manderson. It repeats results already reported in the quarterly; no new information is visible in the text provided.
Administrative notice that the September quarterly report will be released on 27 October 2023, with an investor and analyst call at 11:30am AEDT. No new business information.
The BP33 resource rose to 10.5Mt @ 1.53% Li2O from 10.1Mt @ 1.48%. The Measured and Indicated share rose to 9.36Mt (89%), up from 6.94Mt, so more can be considered for conversion to Ore Reserves for the updated feasibility study.
First full-year profit: FY23 revenue A$50.6M, EBITDA A$14.0M, net profit A$10.8M, operating cash flow A$90.8M, cash about A$153M, no debt. FID for BP33 remains on track for the March quarter.
The 2023 Annual Report covers the first year of production: 18,274t concentrate produced, revenue A$50.6M, cash A$152.8M, no debt. It restates the 30.6Mt Finniss resource and FY24 guidance, with no new announcements in the visible text.
The share purchase plan raised about A$11.4M, issuing 28,418,750 shares at A$0.40, below the A$20M target. With the A$100M placement, total equity raised is about A$111.4M.
What it means for a shareholder
28.4m new shares at A$0.400 to raise about A$11.4m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
The first 10,000t concentrate delivery into Ganfeng's long-term offtake and the first 15,000t fines parcel (1.2% Li2O) have been loaded on the Clearwater Bay at Darwin, bound for China. Concentrate is priced on a formula linked to the lithium spot price.
BP33 box cut excavation has started, with the A$45-50M early works and updated feasibility study on track for a Q1 CY24 investment decision. Carlton infill drilling is finished, with results such as 25m @ 1.32% Li2O; the Carlton study update is due by end-2024.
The share purchase plan opened, letting eligible shareholders buy up to A$30,000 of shares at A$0.40, targeting about A$20M and closing 15 September. ASX granted the waiver needed. SPP funds are for working capital.
A 10,000t concentrate parcel, the first into long-term offtake (to Ganfeng), is at Darwin ready for export, within contract specs. A first 15,000t fines parcel (1.2% Li2O) is also nearly at port, giving an outlet for material while recovery work continues.
17 Aug 2023capital raising announcement● NeutralMajor
The A$100M placement at A$0.40 completed, issuing 250 million new shares, backed by existing and new institutional investors. Funds go to BP33 early works, recovery improvements and exploration. The SPP (up to A$20M, A$0.40) follows, closing 15 September.
Equity raising presentation supporting the A$100M placement and A$20M SPP at A$0.40 announced the same day. The visible text is only disclaimers and notices, with no additional information in the provided portion.
16 Aug 2023capital raising announcement● NeutralMajor
Core launched a fully underwritten A$100M placement at A$0.40 a share, plus a non-underwritten A$20M share purchase plan at the same price. Funds go to BP33 early works, plant optimisation, exploration and study work during ramp-up. Pro forma cash is about A$201-221M.
CEO presentation at the Diggers and Dealers conference. The visible text is only disclaimers and cautionary notes, with no new information in the provided portion.
BP33 early works (A$45-50M box cut and surface works) and the detailed feasibility study have started, with contractor NAC on site. The investment decision remains due in Q1 CY24. This repeats the previously announced plan.
June quarter results presentation by the CEO. The visible text is only disclaimers and cautionary notes, with no new information in the provided portion.
First production guidance: FY24 sales of 90,000-100,000t at C1 cost A$1,165-1,250/t, with output and costs worse than the 2021 feasibility study (recoveries about 49%). FY25 output is expected to be below FY24. Cash was A$152.7M with no debt.
Administrative notice of an investor and analyst conference call on the June quarter results at 11:00am AEST on 24 July 2023. No new business information.